iShares NASDAQ Biotechnology ETF
ALTAR
Score™
0.7% info Recommen-
dation
AVOID
2020E    2021E
P/E
ratio
107.2x P/Sales
ratio
5.8x
P/BV
ratio
4.8x Div.
yield
0.7%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.

FUND BASICS
Category US Equities
Fund Sponsor Barclays Global Investors
Website www.ishares.com
Inception date Feb 09, 2001
Assets (mns) $6,703
Currency USD
Expense ratio 47 bp
Distributions Quarterly

FUND STRUCTURE
Regulation Open-Ended Fund
Custodian State Street Bank & Trust
Weighting Market Cap
Index replication n/a
Uses derivatives No
Options available Yes

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 213
Wgt avg mkt cap (mns) $40,470
Large cap (>$10bn) 58.3%
Mid cap ($2-10bn) 25.8%
Small cap (<$2bn) 15.8%
Developed mkts 99.2%
Emerging mkts 0.8%

TOP TEN HOLDINGS
GILEAD SCIENCES INC 10.0 %
VERTEX PHARMACEUTICALS INC 8.5 %
AMGEN INC 7.8 %
BIOGEN IDEC INC 7.3 %
REGENERON PHARMACEUTICALS 5.9 %
ILLUMINA INC 5.3 %
SEATTLE GENETICS INC 2.8 %
ALEXION PHARMACEUTICALS INC 2.8 %
INCYTE CORP 2.4 %
BIOMARIN PHARMACEUTICAL INC 2.0 %
Total 54.7 %

TOP COUNTRY EXPOSURE
UNITED STATES 89.4 %
IRELAND 2.3 %
BRITAIN 2.2 %
CHINA 1.5 %
FRANCE 1.3 %
DENMARK 0.7 %
NETHERLANDS 0.7 %
SWITZERLAND 0.4 %
SPAIN 0.3 %
BELGIUM 0.2 %

HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru March 31)
Year-to-date 1 year 5 years 10 years Since Incep.
-10.6% -3.4% -1.0% 13.8% 6.7%

Market Correlations
versus... Beta R-squared
S&P500 0.94 46%
MSCI EAFE 0.78 31%
MSCI Emg. Mkts. 0.66 32%

Technical Indicators
Recent close $111.71
30d moving avg. $108.29
Annualized volatility 21.2%
Short interest (ETF) 28.6%
Short interest (Underlying) 5.2%
Relative strength (RSI) 43

Liquidity measures
Avg. volume (thou.) 4,984
Turnover 8.3%
Bid/Ask (% of price) 0.09%
ADV underlying (mns) $11,535

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 100 potential alternatives to the iShares NASDAQ Biotechnology ETF ETF based on the alternatives' overlap in portfolio holdings with IBB. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: IBB Expense: 47 bp ALTAR Score™: 0.7%


ALTERNATIVE ETFs BASED ON OVERLAP WITH IBB
Ticker Fund
Name
Overlap1
vs IBB
(%)
Expense
ratio
(bp)
Savings
vs IBB
(bp)
ALTAR
Score™
(%)
ALTAR
vs IBB
(%)
BBH VanEck Vectors Biotech ETF 57.5 35 12 4.3 +3.6
IEIH iShares Evolved U.S. Innovative Healthcare ETF 47.0 18 29 4.3 +3.6
FBT First Trust NYSE Arca Biotechnology Index Fund 44.5 57 -10 -0.2 -0.9
XBI SPDR S&P BIOTECH ETF 43.8 35 12 -4.9 -5.7
BTEC Principal Healthcare Innovators Index ETF 33.8 42 5 -4.8 -5.5
PBE Invesco Dynamic Biotechnology & Genome ETF 31.9 57 -10 -1.0 -1.8
LNGR Global X Longevity Thematic ETF 25.4 50 -3 4.2 +3.5
FXH First Trust Health Care AlphaDEX Fund 24.9 62 -15 6.2 +5.5
IDNA iShares Genomics Immunology & Healthcare ETF 21.8 47 0 -3.3 -4.1
GNOM Global X Genomics & Biotechnology ETF 21.4 68 -21 -3.7 -4.4
PJP Invesco Dynamic Pharmaceuticals ETF 21.0 56 -9 12.0 +11.3
QQXT First Trust Nasdaq-100 Ex-Technology Sector Index Fund 19.8 60 -13 4.8 +4.1
GDNA Goldman Sachs Motif Human Evolution ETF 18.3 50 -3 0.5 -0.3
VHT Vanguard Health Care Index Fund 18.3 10 37 6.2 +5.5
FHLC Fidelity MSCI Health Care Index ETF 18.1 8 39 6.3 +5.6
JHMH John Hancock Multifactor Healthcare ETF 17.7 40 7 6.9 +6.1
IYH iShares U.S. Healthcare ETF 16.7 43 4 6.8 +6.0
RYH Invesco S&P 500 Equal Weight Health Care ETF 16.5 40 7 7.5 +6.8
CNCR Loncar Cancer Immunotherapy ETF 16.4 79 -32 -4.3 -5.0
IWO iShares Russell 2000 Growth ETF 16.1 24 23 1.4 +0.7
HELX Franklin Genomic Advancements ETF 15.9 50 -3 -2.2 -3.0
BBC Virtus LifeSci Biotech Clinical Trials ETF 15.6 79 -32 0.0 -0.7
PTH Invesco DWA Healthcare Momentum ETF 15.5 60 -13 -2.9 -3.7
VTWG Vanguard Russell 2000 Growth Index Fund 15.5 15 32 1.7 +0.9
XLV Health Care Select Sector SPDR Fund 13.8 13 34 7.7 +7.0
QQEW First Trust Nasdaq-100 Equal Weighted Index Fund 11.8 60 -13 5.2 +4.5
QQQE Direxion NASDAQ-100 Equal Weighted Index Shares 11.8 35 12 5.5 +4.7
ARKG ARK Genomic Revolution Multi-Sector ETF 11.6 75 -28 -26.5 -27.2
VBK Vanguard Small-Cap Growth Index Fund 11.2 7 40 3.7 +2.9
SDG iShares Sustainable MSCI Global Impact ETF 11.2 49 -2 7.3 +6.6
TECB iShares US Tech Breakthrough Multisector ETF 11.0 40 7 5.1 +4.3
HTEC ROBO Global Healthcare Technology & Innovation ETF 10.7 68 -21 0.9 +0.2
CACG ClearBridge All Cap Growth ETF 10.4 54 -7 5.3 +4.6
XT iShares Exponential Technologies ETF 10.2 47 0 6.5 +5.8
IWM iShares Russell 2000 ETF 10.1 19 28 5.2 +4.4
FNY First Trust Mid Cap Growth AlphaDEX Fund 10.0 70 -23 4.2 +3.5
VTWO Vanguard Russell 2000 Index Fund 9.8 10 37 5.4 +4.6
SBIO ALPS Medical Breakthroughs ETF 9.4 50 -3 -1.3 -2.0
IXJ iShares Global Healthcare ETF 9.3 46 1 6.9 +6.1
BOSS Global X Founder-Run Companies ETF 9.0 45 2 4.4 +3.7
VFMO Vanguard U.S. Momentum Factor ETF 8.9 13 34 4.4 +3.6
COWZ Pacer US Cash Cows 100 ETF 8.9 49 -2 13.1 +12.3
DVP Deep Value ETF 8.7 59 -12 20.9 +20.2
ENTR Entrepreneur 30 Fund 8.6 49 -2 3.2 +2.5
BOUT Innovator IBD Breakout Opportunities ETF 8.1 80 -33 5.2 +4.5
SCHA Schwab U.S. Small-Cap ETF 7.8 4 43 6.9 +6.2
JKK iShares Morningstar Small-Cap Growth ETF 7.7 30 17 2.0 +1.3
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 7.5 21 26 4.1 +3.3
PBSM Invesco PureBeta MSCI USA Small Cap ETF 7.3 6 41 7.4 +6.7
IWC iShares Micro-Cap ETF 7.2 60 -13 -4.7 -5.5
ESML iShares MSCI USA Small-Cap ESG Optimized ETF 7.1 17 30 6.8 +6.1
FAD First Trust Multi Cap Growth AlphaDEX Fund 7.0 66 -19 3.9 +3.2
QVAL Alpha Architect U.S. Quantitative Value ETF 6.9 49 -2 16.4 +15.7
VXF Vanguard Extended Market Index Fund 6.9 7 40 5.5 +4.8
SHE SPDR SSGA Gender Diversity Index ETF 6.9 20 27 7.0 +6.3
QYLD Global X NASDAQ 100 Covered Call ETF 6.9 60 -13 4.7 +3.9
DWAS Invesco DWA SmallCap Momentum ETF 6.8 60 -13 -1.1 -1.9
PQSG PGIM QMA Strategic Alpha Small-Cap Growth ETF 6.7 29 18 3.2 +2.5
SPHQ Invesco S&P 500 Quality ETF 6.7 15 32 6.1 +5.3
NUSI Nationwide Risk-Managed Income ETF 6.6 68 -21 4.6 +3.9
QGRO American Century STOXX U.S. Quality Growth ETF 6.5 29 18 4.3 +3.5
PKW Invesco Buyback Achievers ETF 6.5 62 -15 8.9 +8.2
VB Vanguard Small-Cap ETF 6.4 5 42 7.6 +6.9
JKH iShares Morningstar Mid-Cap Growth ETF 6.4 30 17 3.4 +2.6
QQQ Invesco QQQ Trust 6.3 20 27 5.1 +4.3
ARKK ARK Innovation ETF 6.3 75 -28 -4.3 -5.1
FPX First Trust US IPO Index Fund 6.3 59 -12 5.4 +4.7
XPH SPDR S&P Pharmaceuticals ETF 6.1 35 12 5.9 +5.2
MOAT VanEck Vectors Morningstar Wide Moat ETF 6.0 49 -2 7.6 +6.8
IHE iShares U.S. Pharmaceuticals ETF 6.0 42 5 6.1 +5.4
NUSC Nuveen ESG Small-Cap ETF 6.0 40 7 7.1 +6.3
SFYX Sofi Next 500 ETF 5.9 0 47 7.7 +7.0
SFYF SoFi 50 ETF 5.9 29 18 8.0 +7.3
SPGP Invesco S&P 500 GARP ETF 5.8 35 12 10.0 +9.3
PWV Invesco Dynamic Large Cap Value ETF 5.8 55 -8 10.1 +9.4
MTUM iShares Edge MSCI USA Momentum Factor ETF 5.7 15 32 5.8 +5.1
VFLQ Vanguard U.S. Liquidity Factor ETF 5.7 13 34 5.1 +4.3
FNX First Trust Mid Cap Core AlphaDEX Fund 5.7 61 -14 9.6 +8.9
BIBL Inspire ETF 5.6 35 12 5.8 +5.1
FYC First Trust Small Cap Growth AlphaDEX Fund 5.5 70 -23 3.4 +2.6
FCTR First Trust Lunt U.S. Factor Rotation ETF 5.2 65 -18 4.1 +3.4
FLAG FLAG-Forensic Accounting Long Short ETF 5.2 152 -105 11.1 +10.3
USVM VictoryShares USAA MSCI USA Small Cap Value Momentum ETF 5.2 24 23 10.4 +9.6
DSTL Distillate US Fundamental Stability & Value ETF 5.1 39 8 7.3 +6.6
JKF iShares Morningstar Large Cap Value ETF 5.1 25 22 9.1 +8.4
SYG SPDR MFS Systematic Growth Equity ETF 5.0 60 -13 6.0 +5.2
JHSC John Hancock Multifactor Small Cap ETF 5.0 50 -3 8.2 +7.4
RNDV US Equity Dividend Select ETF 5.0 50 -3 10.0 +9.3
FTHI First Trust High Income ETF 4.9 85 -38 7.2 +6.5
GSSC Goldman Sachs Activebeta U.S. Small Cap Equity ETF 4.9 20 27 8.3 +7.6
FTXH First Trust Nasdaq Pharmaceuticals ETF 4.9 60 -13 7.5 +6.8
TUSA First Trust Total US Market AlphaDEX ETF 4.9 70 -23 8.7 +8.0
JQUA JPMorgan U.S. Quality Factor ETF 4.8 12 35 6.3 +5.5
MXDU Nationwide Maximum Diversification US Core Equity ETF 4.8 34 13 6.4 +5.7
AIEQ AI Powered Equity ETF 4.8 87 -40 4.7 +4.0
AFSM First Trust Active Factor Small Cap ETF 4.7 75 -28 8.9 +8.2
FCPI Fidelity Stocks for Inflation ETF 4.7 29 18 8.6 +7.9
KRMA Global X Conscious Companies ETF 4.4 43 4 7.0 +6.2
JSMD Janus Henderson Small/Mid Cap Growth Alpha ETF 4.4 35 12 7.3 +6.6
DGRW WisdomTree U.S. Quality Dividend Growth Fund 4.4 28 19 7.8 +7.1

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2015 2016 2017 2018 2019 2020E 2021E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2019 2020E 2021E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
iShares NASDAQ Biotechnology ETF
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 5.7 %
Divided by: Fwd. P/BV 4.7 x
Less: Expense ratio 47 bp
Equals: ALTAR Score 0.7 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.40 CATEGORY
AVERAGE
1.51
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.